About Alsachim
Alsachim is a company based in Illkirch-graffenstaden (France) founded in 2005 by Jean-Francois Hoeffler was acquired by Shimadzu Corporation in June 2017.. Alsachim offers products and services including Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis. Alsachim operates in a competitive market with competitors including ARTMS, NorthStar Medical Radioisotopes, Niowave, Ground Fluor Pharmaceuticals and AZI, among others.
- Headquarter Illkirch-graffenstaden, France
- Founders Jean-Francois Hoeffler
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Shimadzu Corporation
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Shimadzu Corporation
(Jun 21, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alsachim
Alsachim offers a comprehensive portfolio of products and services, including Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Standards for precise laboratory analysis and testing
Products for accurate chemical reference in diagnostics
Kits like DOSIMMUNE for specific clinical applications
Tailored synthesis services for research needs
Funding Insights of Alsachim
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2006 | Amount | Private Equity Round - Alsachim | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alsachim
Alsachim has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Shimadzu Corporation and Naxicap. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in small and medium-sized businesses are managed by Naxicap.
|
Founded Year | Domain | Location | |
|
Medical imaging systems, industrial machinery, and analytical instruments are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alsachim
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alsachim
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alsachim Comparisons
Competitors of Alsachim
Alsachim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, NorthStar Medical Radioisotopes, Niowave, Ground Fluor Pharmaceuticals and AZI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| domain | founded_year | HQ Location |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| domain | founded_year | HQ Location |
Devices and radioisotopes for nuclear imaging are provided by Niowave.
|
|
| domain | founded_year | HQ Location |
Proprietary chemistry for pharmaceutical synthesis is developed by the company.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for diagnostic imaging are developed and produced.
|
|
| domain | founded_year | HQ Location |
Multimodal visualization agents are developed for image-guided interventions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Alsachim
When was Alsachim founded?
Alsachim was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Where is Alsachim located?
Alsachim is headquartered in Illkirch-graffenstaden, France. It is registered at Illkirch-graffenstaden, Bas-rhin, France.
Who is the current CEO of Alsachim?
Jean-Francois Hoeffler is the current CEO of Alsachim. They have also founded this company.
What does Alsachim do?
Alsachim was founded in 2005 and is based in Illkirch Graffenstaden, France. Operations focus on the pharmaceutical and biotechnology industries, where custom synthesis of stable isotopically labeled molecules is conducted, including intermediates, reference standards, metabolites, peptides, and biologically active compounds. Analytical services, such as HPLC, mass spectrometry, and NMR analysis, are also offered to support research and development needs in these sectors.
Who are the top competitors of Alsachim?
Alsachim's top competitors include ARTMS, NorthStar Medical Radioisotopes and Niowave.
What products or services does Alsachim offer?
Alsachim offers Stable Labeled Standards, Reference Standards, Reagent Kits, and Custom Synthesis.
Who are Alsachim's investors?
Alsachim has 2 investors. Key investors include Shimadzu Corporation, and Naxicap.